Table 1.
Study, year | COVID-19 positive | COVID-19 negative |
---|---|---|
↓ Lymphocytes (percentage of patients) | ||
Elshafeey et al.(Elshafeey et al., 2020) | 14 | – |
Juan et al.(Juan et al., 2020) | 43.1 | – |
Li et al.(Li et al., 2020) | 12.5 | 12.6 |
Wu et al.(Wu et al., 2020) | 12.5 | 0 |
WBC Count | ||
Elshafeey et al.(Elshafeey et al., 2020) | – | – |
Juan et al.(Juan et al., 2020) | ↓/Normal | – |
Li et al.(Li et al., 2020) | Normal | ↑ |
Wu et al.(Wu et al., 2020) | Normal | ↑ |
↑ CRP (percentage of patients) | ||
Elshafeey et al.(Elshafeey et al., 2020) | 18.7 | – |
Juan et al.(Juan et al., 2020) | 45.7 | – |
Li et al.(Li et al., 2020) | 32.1 | 58.1 |
Wu et al.(Wu et al., 2020) | 0 | 0 |
Percentage of patients with: Low (↓), High (↑), or non-available data (-).
WBC: White blood cells.